Abbott Laboratories to Resume Baby Formula Production Under Consent Decree
According to the United States Department of Justice, a complaint and a proposed consent decree were filed in the U.S. District Court for the Western District of Michigan on May 16, 2022. If approved by the court, Abbott Nutrition would be allowed to take corrective actions at its Sturgis, Michigan facility and resume manufacturing … [Read more...] about Abbott Laboratories to Resume Baby Formula Production Under Consent Decree
Depakote Anti-Epilepsy Medication Linked to Birth Defects
The family of a 12-year-old child has filed a lawsuit on behalf of the young girl who underwent an extremely difficult operation, along with her mother, while she was still in the womb. The highly complicated open fetal surgery took place at Vanderbilt University Medical Center in Nashville, Tennessee. The operation was an attempt to … [Read more...] about Depakote Anti-Epilepsy Medication Linked to Birth Defects
FDA to Increase Regulation of Infusion Pumps
More Stiffer Infusion Pumps Regulation Sought. The Food & Drug Administration (FDA) has undertaken an initiative to boost the safety of infusion pumps. Infusion pumps are marketed by a number of firms, including Baxter International Inc, Abbott Laboratories Inc, Hospira Inc and CareFusion. According to the FDA, it … [Read more...] about FDA to Increase Regulation of Infusion Pumps
FDA Issues Warning About Humira Ad
FDA Warning Over Abbot's Humira. Abbott Laboratories is in more hot water over its Humira advertising. Federal regulators warned Abbott about its advertisements for the company's psoriasis drug, saying the ad is misleading and makes claims not supported by scientific evidence. According to Dow Jones, the Humira (generic: Adalimumab) … [Read more...] about FDA Issues Warning About Humira Ad
